2023 clinical immunization safety assessment (CISA) base IDIQ

Active Awarded Last action

Contract number
75D30123F00001
Awardee
Awarding agency
Obligated
$5,279,183

Award facts

Opportunity
  • 75D30123R72860 Solicitation number
Contract value 79% obligated
  • $5,286,959.00 Current, with exercised options
  • $6,648,584.00 Potential, with all options
Completion date 62% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Nashville, TN 37232, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00007 · Cisa clinical vaccine safety evaluation - lead EO 14398 $1,337,071
Other Administrative Action P00006 · EO 14398 $0
Exercise an Option P00005 $1,324,433
Other Administrative Action P00004 $0
Exercise an Option P00003 $1,312,043
Supplemental Agreement for work within scope P00002 $5,740
Supplemental Agreement for work within scope P00001 $0
Original award $1,299,896

About this award

The Centers for Disease Control and Prevention Pittsburgh issued a delivery order to Vanderbilt University Medical Center on September 28, 2023, under the Clinical Immunization Safety Assessment (CISA) 2023–2028 IDIQ, with a ceiling value of $6.648 million and ultimate completion date of September 27, 2028. The order supports clinical vaccine safety evaluation under Executive Order 14398 and is structured as cost, no fee.

Place of performance is Nashville, TN 37232. The CISA IDIQ provides clinical immunization safety assessment services to CDC across the base and option periods.

Government-invoiced service contract labor through FY2025 totaled $2 million across 4.5 FTEs (FY2025) and 3.1 FTEs in FY2024, when 6,382 contractor hours were billed at a derived government-paid rate of $156.68 per hour. Vanderbilt University Medical Center self-performed all reported hours with no subcontractor engagement in FY2025. Year-over-year invoiced dollars grew from $1 million in FY2024 to $1 million in FY2025, while the FTE footprint increased from 3.1 to 4.5.

Quick answers

Who was awarded contract 75D30123F00001?

75D30123F00001 was awarded to Vanderbilt University Medical Center by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 28, 2023.

How much is contract 75D30123F00001 worth?

The government has obligated $5,279,183 on 75D30123F00001. Its current value, with exercised options, is $5,286,959. Its potential value, with all options, is $6,648,584.

Is contract 75D30123F00001 an order under another contract?

Yes. 75D30123F00001 is a delivery order under 75D30123D17951, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).

Was contract 75D30123F00001 competed?

The extent of competition for 75D30123F00001 was full and open competition. The government received 10 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award